188 related articles for article (PubMed ID: 37190077)
21. Epigenetic dysregulation in the developing Down syndrome cortex.
El Hajj N; Dittrich M; Böck J; Kraus TF; Nanda I; Müller T; Seidmann L; Tralau T; Galetzka D; Schneider E; Haaf T
Epigenetics; 2016 Aug; 11(8):563-78. PubMed ID: 27245352
[TBL] [Abstract][Full Text] [Related]
22. Integrated analysis of DNA methylation and RNA‑sequencing data in Down syndrome.
Zhang J; Zhou W; Liu Y; Li N
Mol Med Rep; 2016 Nov; 14(5):4309-4314. PubMed ID: 27667480
[TBL] [Abstract][Full Text] [Related]
23. Analysis of microRNA expression profile by small RNA sequencing in Down syndrome fetuses.
Xu Y; Li W; Liu X; Ma H; Tu Z; Dai Y
Int J Mol Med; 2013 Nov; 32(5):1115-25. PubMed ID: 24071828
[TBL] [Abstract][Full Text] [Related]
24. Plasma Amyloid Beta 1-42 and DNA Methylation Pattern Predict Accelerated Aging in Young Subjects with Down Syndrome.
Obeid R; Hübner U; Bodis M; Geisel J
Neuromolecular Med; 2016 Dec; 18(4):593-601. PubMed ID: 27234618
[TBL] [Abstract][Full Text] [Related]
25. Identification of a DNA methylation signature in blood cells from persons with Down Syndrome.
Bacalini MG; Gentilini D; Boattini A; Giampieri E; Pirazzini C; Giuliani C; Fontanesi E; Scurti M; Remondini D; Capri M; Cocchi G; Ghezzo A; Del Rio A; Luiselli D; Vitale G; Mari D; Castellani G; Fraga M; Di Blasio AM; Salvioli S; Franceschi C; Garagnani P
Aging (Albany NY); 2015 Feb; 7(2):82-96. PubMed ID: 25701644
[TBL] [Abstract][Full Text] [Related]
26. Genetic mechanisms involved in the phenotype of Down syndrome.
Patterson D
Ment Retard Dev Disabil Res Rev; 2007; 13(3):199-206. PubMed ID: 17910086
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive investigation of DNA methylation and gene expression in trisomy 21 placenta.
Lim JH; Kim SY; Han JY; Kim MY; Park SY; Ryu HM
Placenta; 2016 Jun; 42():17-24. PubMed ID: 27238709
[TBL] [Abstract][Full Text] [Related]
28. Spatial and Temporal Expression of High-Mobility-Group Nucleosome-Binding (HMGN) Genes in Brain Areas Associated with Cognition in Individuals with Down Syndrome.
Rodríguez-Ortiz A; Montoya-Villegas JC; García-Vallejo F; Mina-Paz Y
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946949
[TBL] [Abstract][Full Text] [Related]
29. Aberrant expression of signaling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (trisomy 21).
Peyrl A; Weitzdoerfer R; Gulesserian T; Fountoulakis M; Lubec G
Electrophoresis; 2002 Jan; 23(1):152-7. PubMed ID: 11824616
[TBL] [Abstract][Full Text] [Related]
30. Immune cell deconvolution of bulk DNA methylation data reveals an association with methylation class, key somatic alterations, and cell state in glial/glioneuronal tumors.
Singh O; Pratt D; Aldape K
Acta Neuropathol Commun; 2021 Sep; 9(1):148. PubMed ID: 34496929
[TBL] [Abstract][Full Text] [Related]
31. Accelerated epigenetic aging in Down syndrome.
Horvath S; Garagnani P; Bacalini MG; Pirazzini C; Salvioli S; Gentilini D; Di Blasio AM; Giuliani C; Tung S; Vinters HV; Franceschi C
Aging Cell; 2015 Jun; 14(3):491-5. PubMed ID: 25678027
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide microRNA expression profiling in placentas of fetuses with Down syndrome.
Lim JH; Kim DJ; Lee DE; Han JY; Chung JH; Ahn HK; Lee SW; Lim DH; Lee YS; Park SY; Ryu HM
Placenta; 2015 Mar; 36(3):322-8. PubMed ID: 25595853
[TBL] [Abstract][Full Text] [Related]
33. Reduction of chromatin assembly factor 1 p60 and C21orf2 protein, encoded on chromosome 21, in Down syndrome brain.
Shim KS; Bergelson JM; Furuse M; Ovod V; Krude T; Lubec G
J Neural Transm Suppl; 2003; (67):117-28. PubMed ID: 15068244
[TBL] [Abstract][Full Text] [Related]
34. Genetic and epigenetic pathways in Down syndrome: Insights to the brain and immune system from humans and mouse models.
Yu YE; Xing Z; Do C; Pao A; Lee EJ; Krinsky-McHale S; Silverman W; Schupf N; Tycko B
Prog Brain Res; 2020; 251():1-28. PubMed ID: 32057305
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiling in the adult Down syndrome brain.
Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S
Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572
[TBL] [Abstract][Full Text] [Related]
36. PRDM8 internal promoter hyperhydroxymethylation correlates with increased expression of the corresponding transcript in Down syndrome.
Lu Z; Liu Y; Ren Z; Yan J
Mol Med Rep; 2016 Aug; 14(2):1227-34. PubMed ID: 27278638
[TBL] [Abstract][Full Text] [Related]
37. HiTIMED: hierarchical tumor immune microenvironment epigenetic deconvolution for accurate cell type resolution in the tumor microenvironment using tumor-type-specific DNA methylation data.
Zhang Z; Wiencke JK; Kelsey KT; Koestler DC; Christensen BC; Salas LA
J Transl Med; 2022 Nov; 20(1):516. PubMed ID: 36348337
[TBL] [Abstract][Full Text] [Related]
38. Unaltered expression of Fas (CD95/APO-1), caspase-3, Bcl-2 and annexins in brains of fetal Down syndrome: evidence against increased apoptosis.
Engidawork E; Balic N; Juranville JF; Fountoulakis M; Dierssen M; Lubec G
J Neural Transm Suppl; 2001; (61):149-62. PubMed ID: 11771740
[TBL] [Abstract][Full Text] [Related]
39. Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations.
Toiber D; Azkona G; Ben-Ari S; Torán N; Soreq H; Dierssen M
Neurobiol Dis; 2010 Oct; 40(1):348-59. PubMed ID: 20600907
[TBL] [Abstract][Full Text] [Related]
40. Effect of the one‑carbon unit cycle on overall DNA methylation in children with Down's syndrome.
Song C; He J; Chen J; Liu Y; Xiong F; Wang Y; Li T
Mol Med Rep; 2015 Dec; 12(6):8209-14. PubMed ID: 26497014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
